Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized Withdrawal, Double-blind, Parallel, Placebo-controlled Design Clinical Trial of Toludesvenlafaxine Hydrochloride Extended-Release Tablets

NCT06426485 is registered in ClinicalTrials.gov with Luye Pharma Group Ltd. as lead sponsor.

NCT NCT06426485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06426485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized Withdrawal, Double-blind, Parallel, Placebo-controlled Design Clinical Trial of Toludesvenlafaxine Hydrochloride Extended-Release Tablets
Lead sponsor
Luye Pharma Group Ltd.
Phase
Phase 4
Overall status
Not yet recruiting
Start date
May 30, 2024
Completion date
June 30, 2027
Enrollment
736 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder